公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Effectiveness of the 10 cm2 Rivastigmine Patch in Taiwanese Patients with Mild-to-Moderate Alzheimer’s Dementia: A 48-Week Real-World Observational Study | Chang C.-C.; Chan L.; Chou H.-H.; Yang Y.-W.; TA-FU CHEN ; Chen T.-B.; Chen C.-I.; Yang A.; Hu C.-J. | Advances in Therapy | 0 | 0 | |
2020 | Efficient in Utero Gene Transfer to the Mammalian Inner Ears by the Synthetic Adeno-Associated Viral Vector Anc80L65 | Hu C.-J.; Lu Y.-C.; Tsai Y.-H.; Cheng H.-Y.; Takeda H.; Huang C.-Y.; Xiao R.; Hsu C.-J.; Tsai J.-W.; Vandenberghe L.H.; Chen-Chi Wu ; Cheng Y.-F. | Molecular Therapy - Methods and Clinical Development | 11 | 11 | |
2017 | Elevated Plasma Level of Soluble Form of RAGE in Ischemic Stroke Patients with Dementia | SUNG-CHUN TANG ; KAI-CHIEN YANG ; Hu C.-J.; Chiou H.-Y.; CHAU-CHUNG WU ; JIANN-SHING JENG | NeuroMolecular Medicine | 19 | 18 | |
2014 | Energy adaptive response during parthanatos is enhanced by PD98059 and involves mitochondrial function but not autophagy induction | Huang C.-T.; Huang D.-Y.; Hu C.-J.; Wu D.; WAN-WAN LIN | Biochimica et Biophysica Acta - Molecular Cell Research | 17 | 13 | |
2009 | The epigenetic effects of amyloid-£]1-40 on global DNA and neprilysin genes in murine cerebral endothelial cells | Chen K.-L.; Wang S.S.-S. ; Yang Y.-Y.; Yuan R.-Y.; Chen R.-M.; Hu C.-J. | Biochemical and Biophysical Research Communications | 124 | 107 | |
2012 | Epistasis Analysis for Estrogen Metabolic and Signaling Pathway Genes on Young Ischemic Stroke Patients | Hsieh Y.-C.; JIANN-SHING JENG ; Lin H.-J.; Hu C.-J.; Yu C.-C.; Lien L.-M.; Peng G.-S.; Chen C.-I.Chin-I.; SUNG-CHUN TANG ; Chi N.-F.; Tseng H.-P.; Chern C.-M.; Hsieh F.-I.Fang-I.; Bai C.-H.; Chen Y.-R.; Chiou H.-Y.; SHIN-JOE YEH ; LI-KAI TSAI ; Kong S.; Chiu H.-C.; Chen W.-H.; Huang T.-H.; Lau C.-I.; Wu Y.-Y.; Yuan R.-Y.; Sheu J.-J.; Yu J.-M.; Ho C.-S.; Chen C.-I.; Sung J.-Y.; Weng H.-Y.; Han Y.-H.; Huang C.-P.; Chung W.-T.; Ke D.-S.; Chang C.-Y.; Yeh P.-S.; Lin K.-C.; Cheng T.-J.; Chou C.-H.; Yang C.-M.; Lin J.-C.; Hsu Y.-D.; Denq J.-C.; Lee J.-T.; Hsu C.-H.; Lin C.-C.; Yen C.-H.; Cheng C.-A.; Sung Y.-F.; Chen Y.-L.; Lien M.-T.; Liu C.-C.; Yang F.-C.; Wu Y.-C.; Tso A.-C.; Lai Y.-H.; Chiang C.-I.; Tsai C.-K.; Liu M.-T.; Lin Y.-C.; Hsu Y.-C.; Chen C.-H.; Sung P.-S.; Hu H.-H.; Wong W.-J.; Luk Y.-O.; Hsu L.-C.; Chung C.-P.; Liu C.-H.; Lin C.-L.; Lin H.-C. | PLoS ONE | 10 | 9 | |
2013 | Functional role of soluble receptor for advanced glycation end products in stroke | SUNG-CHUN TANG ; Wang Y.-C.; Li Y.-I.; Lin H.-C.; Manzanero S.; Hsieh Y.-H.; Phipps S.; Hu C.-J.; Chiou H.-Y.; Huang Y.-S.; WEI-SHIUNG YANG ; Mattson M.P.; Arumugam T.V.; JIANN-SHING JENG | 70 | 70 | ||
2019 | Generation of a human iPS cell line (CGMH.SLC26A4919-2) from a Pendred syndrome patient carrying SLC26A4 c.919-2A>G splice-site mutation | Cheng Y.-F.; Chan Y.-H.; Hu C.-J.; Lu Y.-C.; Saeki T.; Hosoya M.; Saegusa C.; Fujioka M.; Okano H.; Weng S.-M.; Hsu C.-J.; Chang K.-H.; Chen-Chi Wu | Stem Cell Research | 5 | 4 | |
2020 | HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen-glucose deprivation injuries via H3K14 and H4K5 acetylation-mediated BDNF expression | Fang Y.-C.; Chan L.; Liou J.-P.; YONG-KWANG TU ; Lai M.-J.; Chen C.-I.; Vidyanti A.N.; Lee H.-Y.; Hu C.-J. | Journal of Cellular and Molecular Medicine | 9 | 8 | |
2011 | High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease | TSUNG-YANG WANG ; Hu C.-J.; Kuo C.-W.; Chen Y.; Lin J.-L.; Yang C.-W.; Yen T.-H. | Nephrology | 16 | 15 | |
2016 | Homozygous ALDH2*2 is an Independent Risk Factor for Ischemic Stroke in Taiwanese Men | Sung Y.-F.; Lu C.-C.; Lee J.-T.; Hung Y.-J.; Hu C.-J.; JIANN-SHING JENG ; Chiou H.-Y.; Peng G.-S. | Stroke | 28 | 26 | |
2020 | Imaging-based pregenetic screening for NOTCH3 p.R544C mutation in ischemic stroke in Taiwan | Cheng Y.-W.; CHIH-HAO CHEN ; Hu C.-J.; Chiou H.-Y.; SUNG-CHUN TANG ; JIANN-SHING JENG | Annals of Clinical and Translational Neurology | 5 | 6 | |
2015 | Impact of diabetes on stroke risk and outcomes: Two nationwide retrospective cohort studies | Liao C.-C.; Shih C.-C.; Yeh C.-C.; YI-CHENG CHANG ; Hu C.-J.; Lin J.-G.; Chen T.-L. | Medicine (United States) | 40 | 41 | |
2017 | Increased diabetes risk and interaction with social and medical events in patients upon stroke: Two nationwide studies | Chu L.-M.; Liu C.-C.; Yeh C.-C.; YI-CHENG CHANG ; Hu C.-J.; Shih C.-C.; Cherng Y.-G.; Chen T.-L.; Liao C.-C. | Atherosclerosis | 5 | 4 | |
2021 | Interactive Effects of a Combination of the HDAC3 and HDAC9 Genes with Diabetes Mellitus on the Risk of Ischemic Stroke | Chiou H.-Y.; Bai C.-H.; Lien L.-M.; Hu C.-J.; JIANN-SHING JENG ; SUNG-CHUN TANG ; Lin H.-J.; Hsieh Y.-C. | Thrombosis and Haemostasis | 3 | 3 | |
2021 | Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction | Liu H.-C.; Chen H.-H.; Ho C.-S.; Chang J.-F.; Lin C.-C.; MING-JANG CHIU ; TA-FU CHEN ; Hu C.-J.; Yan S.-H.; Sun Y.; Yang S.-Y. | Neurology and Therapy | 0 | 0 | |
2020 | Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease – A cross-validation study | MING-JANG CHIU ; TA-FU CHEN ; Hu C.-J.; Yan S.-H.; Sun Y.; Liu B.-H.; Chang Y.-T.; Yang C.-C.; Yang S.-Y. | Nanomedicine: Nanotechnology, Biology, and Medicine | 21 | 19 | |
2019 | One-Year Risk of Recurrent Stroke and Death Associated with Vertebrobasilar Artery Stenosis and Occlusion in a Cohort of 10,515 Patients | Qureshi A.I.; Qureshi M.H.; Lien L.-M.; Lee J.-T.; JIANN-SHING JENG ; Hu C.-J.; Lai T.-C.; Liu C.-H.; Chen C.-H.; Chen P.-L.; Chen T.-S.; Li J.-Y.; Lin C.-L.; Hsu C.Y. | Cerebrovascular Diseases | 12 | 10 | |
2013 | Onset headache predicts good outcome in patients with first-ever ischemic stroke | Chen P.-K.; Chiu P.-Y.; Tsai I.-J.; Tseng H.-P.; Chen J.-R.; SHIN-JOE YEH ; Sheu J.-J.; Chung C.-P.; Wu M.-H.; Hu C.-J.; Chang C.-Y.; Wei C.-Y.; Yip P.-K.; Sung S.-F.; Wang S.-J.; Hsu C.Y. | Stroke | 32 | 28 | |
2021 | Pathological circulating factors in moyamoya disease | Fang Y.-C.; Wei L.-F.; Hu C.-J.; YONG-KWANG TU | International Journal of Molecular Sciences | 16 | 14 |